Topic: Cardiology

Abbott (NYSE:ABT) this week announced it received CE Mark for its Gallant implantable cardioverter-defibrillator and cardiac […]

BioSig Technologies (NSDQ:BSGM) announced today that it successfully completed 100 patient cases with its Pure EP […]

Cardiovalve (Or Yehuda, Israel) said today that U.S. FDA has granted a breakthrough device designation for […]

Dive Brief: Teleflex has struck a $260 million deal to buy IWG High Performance Conductors […]

Boston Children’s Hospital is touting a new design that could allow children to maintain the […]

Abbott Laboratories has won CE mark for the new Gallant implantable cardioverter-defibrillator (ICD) and CRT-D […]

Breakthrough Technology Enables Super-Fast Electrical Mapping and Re-Mapping of the Entire Heart Chamber – Leading […]

Dive Brief: Awaiting a Medicare reimbursement decision any day for its MitraClip transcatheter mitral valve […]

Just starting to learn about all of the medical devices out there for treating cardiovascular […]

JenaValve Technology announced that it raised $50 million in equity financing as it develops and manufactures […]

CHF Solutions (NSDQ:CHFS) announced today that it initiated distribution agreements with Neucomed Group and its affiliates to cover […]

BIOTRONIK won the European CE Mark for its Orsiro Mission drug-eluting stent. The device is […]

Scientists at University of Bordeaux/French National Institute of Health and Medical Research (Inserm) have developed […]

Dive Brief: A study of heart rate sensors on six wearable device models found accuracy […]

The FDA has cleared what it describes as the first software that uses AI to […]

Engineers at Rutgers University have developed a robot that autonomously draws patient blood and immediately […]

Medtronic’s second run at bringing a renal denervation treatment to market in the U.S. reaches […]

Heart valve maker JenaValve Technology has raised $50 million in new venture capital funding, not […]

Aria CV announced that it won FDA breakthrough device designation for its pulmonary hypertension (PH) system […]

The FDA announced today that it authorized the marketing of Caption Health’s Caption Guidance software for assisting […]

Caption Guidance™ uses artificial intelligence to empower medical professionals without specialized training to perform cardiac […]

The European Union cleared Profusa’s Wireless Lumee Oxygen Platform, a system designed to measure tissue […]

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals […]

BioVentrix has received the renewal of the highest priority reimbursement in Germany for its transcatheter […]

Dive Brief: CMS is reconsidering how it covers artificial hearts and ventricular assist devices after […]

Michel Mirowski and his colleagues gave the field of implantable cardioverter-defibrillators (ICDs) a pretty good start, […]

Abbott (NYSE:ABT) announced today that it won FDA breakthrough device designation for its in-development fully implantable […]

Lately, it seems as if Abbott Laboratories has been extremely busy building its structural heart […]

  Massachusetts Institute of Technology announced that engineers at the institute, along with others elsewhere, […]

Aortic dissection stent graft maker Ascyrus Medical announced that it sold nearly $5.2 million in an equity […]

Medtronic has announced that its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators […]

Researchers at Monash University in Australia have developed a wearable device that can continuously monitor […]

Dive Brief: Edwards Lifesciences’ nearly 20% year-over-year revenue growth topped Wall Street’s fourth quarter revenue […]

Medtronic (NYSE:MDT) announced today that it has received the CE Mark for its Cobalt and Crome […]

Abbott just announced that it is the first company to receive European regulatory approval to […]

Researchers at the Massachusetts Institute of Technology have developed a bionic hybrid heart designed not […]

A five-year study by Edwards Lifesciences demonstrated no significant differences in the number of deaths […]

Dive Brief: Abbott said Thursday it won the first EU approval for a transcatheter mitral […]

Dive Brief: Five years after undergoing aortic valve replacement, intermediate-risk patients who received an Edwards […]